BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Science '22 in Review
Top Biopharma Trends of 2022
Top Med-tech Trends of 2022
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 29, 2023
See today's BioWorld MedTech
Home
» Genetic Signatures ready to go global with AU$35M raise
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Genetic Signatures ready to go global with AU$35M raise
Nov. 6, 2019
By
Tamra Sami
No Comments
PERTH, Australia – Sydney-based molecular diagnostics company
Genetic Signatures Ltd.
is poised to extend its global footprint to the U.S. and Europe following its AU$35 million (US$24 million) capital raise.
BioWorld MedTech
Diagnostics
Genomics
Asia-Pacific
Australia